Ngā hua rapu kaituhi :: APM

1

<i>APOBEC3B</i>expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation mā David W. Cescon, Benjamin Haibe‐Kains, Tak W. Mak

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
2

Seize the engine: Emerging cell cycle targets in breast cancer mā Jesús Fuentes‐Antrás, Philippe L. Bédard, David W. Cescon

I whakaputaina 2024

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

Evolution of the Randomized Controlled Trial in Oncology Over Three Decades mā Christopher M. Booth, David W. Cescon, Lisa Wang, Ian F. Tannock, Monika K. Krzyzanowska

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis mā Hadar Goldvaser, T. Barnes, Boštjan Šeruga, David W. Cescon, Alberto Ocaña, Domen Ribnikar, Eitan Amir

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
5

Invasive Pulmonary Aspergillosis Associated With Marijuana Use in a Man With Colorectal Cancer mā David W. Cescon, Andrea Page, Susan E. Richardson, Malcolm J. Moore, Scott Boerner, Wayne L. Gold

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Extended Adjuvant Tamoxifen for Early Breast Cancer: A Meta-Analysis mā Mustafa Al-Mubarak, Ariadna Tibau, Arnoud J. Templeton, David W. Cescon, Alberto Ocaña, Boštjan Šeruga, Eitan Amir

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
7

Changes in circulating tumor DNA and outcomes in solid tumors treated with immune checkpoint inhibitors: a systematic review mā Laith Al-Showbaki, Brooke E. Wilson, Faris Tamimi, Consolación Moltó, Abhenil Mittal, David W. Cescon, Eitan Amir

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
8

NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma mā David W. Cescon, Desmond She, Shingo Sakashita, Chang‐Qi Zhu, Melania Pintilie, Frances A. Shepherd, Ming‐Sound Tsao

I whakaputaina 2015

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Ionizable Drugs Enable Intracellular Delivery of Co‐Formulated siRNA mā Kai V. Slaughter, Eric N. Donders, Michael S. Jones, Sami G. Sabbah, Mitchell J. Elliott, Brian K. Shoichet, David W. Cescon, Molly S. Shoichet

I whakaputaina 2024

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Gene isoforms as expression-based biomarkers predictive of drug response in vitro mā Zhaleh Safikhani, Petr Smirnov, Kelsie L. Thu, Jennifer Silvester, Nehmé El-Hachem, Rene Quevedo, Mathieu Lupien, Tak W. Mak, David W. Cescon, Benjamin Haibe‐Kains

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

A risk haplotype in the Solute Carrier Family 22A4/22A5 gene cluster influences phenotypic expression of Crohn’s disease mā William G. Newman, Xiangjun Gu, Richard F. Wintle, David W. Cescon, Mehrdad Yazdanpanah, Xiangdong Liu, Vanya Peltekova, Mark Van Oene, Christopher I. Amos, Katherine A. Siminovitch

I whakaputaina 2005

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts mā Arvind Singh Mer, Wail Ba-Alawi, Petr Smirnov, Yi X. Wang, Ben Brew, Janosch Ortmann, Ming‐Sound Tsao, David W. Cescon, Anna Goldenberg, Benjamin Haibe‐Kains

I whakaputaina 2019

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Genetic Polymorphisms and Head and Neck Cancer Outcomes: A Review mā Jessica Hopkins, David W. Cescon, Darren Tse, Penelope A. Bradbury, Wei Xu, Clement Ma, Paul Wheatley‐Price, John Waldron, David P. Goldstein, François Meyer, Isabelle Bairati, Geoffrey Liu

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
14

TROPION-Breast02: Datopotamab deruxtecan for locally recurrent inoperable or metastatic triple-negative breast cancer mā Rebecca Dent, David W. Cescon, Thomas Bachelot, Kyung Hae Jung, Zhi‐Ming Shao, Shigehira Saji, Tiffany A. Traina, Petra Vuković, Darlington Mapiye, Micah J. Maxwell, Peter Schmid, Javier Cortés

I whakaputaina 2023

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

Functional Characterization of CFI-400945, a Polo-like Kinase 4 Inhibitor, as a Potential Anticancer Agent mā Jacqueline M. Mason, Dan Lin, Wei Xin, Yi Che, Yi Yao, Reza Kiarash, David W. Cescon, Graham C. Fletcher, Donald E. Awrey, Mark R. Bray, Guohua Pan, Tak W. Mak

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer mā Kelsie L. Thu, Jennifer Silvester, Mitchell J. Elliott, Wail Ba-Alawi, Meghan Duncan, Andrea C. Elia, Arvind Singh Mer, Petr Smirnov, Zhaleh Safikhani, Benjamin Haibe‐Kains, Tak W. Mak, David W. Cescon

I whakaputaina 2018

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

Topoisomerase 1 Inhibition in MYC-Driven Cancer Promotes Aberrant R-Loop Accumulation to Induce Synthetic Lethality mā Peter Lin, Corey Lourenco, Jennifer Cruickshank, Luís Palomero, Jenna E. van Leeuwen, Amy H.Y. Tong, Katherine Chan, Samah El Ghamrasni, Miguel Ángel Pujana, David W. Cescon, Jason Moffat, Linda Z. Penn

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperabl... mā Peter Schmid, Mafalda Oliveira, Joyce O’Shaughnessy, Massimo Cristofanilli, Stephanie L. Graff, Seock-Ah Im, Sherene Loi, Shigehira Saji, Shusen Wang, David W. Cescon, Tina Hovey, Agata Nawrot, KY Tse, Petra Vuković, Giuseppe Curigliano

I whakaputaina 2025

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

Functional variants of OCTN cation transporter genes are associated with Crohn disease mā Vanya Peltekova, Richard F. Wintle, Laurence A. Rubin, Christopher I. Amos, Qiqing Huang, Xiangjun Gu, William G. Newman, Mark Van Oene, David W. Cescon, Gordon R. Greenberg, Anne M. Griffiths, Peter St George‐Hyslop, Katherine A. Siminovitch

I whakaputaina 2004

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

Relationship between tumor infiltrating lymphocyte (TIL) levels and response to pembrolizumab (pembro) in metastatic triple-negative breast cancer (mTNBC): Results from KEYNOTE-086 mā Sherene Loi, Sylvia Adams, Peter Schmid, Javier Cortés, David W. Cescon, Eric P. Winer, Deborah Toppmeyer, Hope S. Rugo, Michelino De Laurentiis, Rita Nanda, Hiroji Iwata, Ahmad Awada, Antoinette R. Tan, A. Wang, Gursel Aktan, Vassiliki Karantza, Roberto Salgado

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: